Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Liquidia Corporation(LQDA) | 8,118,592 | 8,118,592 | 0 | $115.53M | $119.75M | 24.99% | +$4.22M |
| Verona Pharma PlcADS | 1,436,878 | 1,436,878 | 0 | $66.73M | $91.23M | 19.04% | +$24.50M |
| Exelixis, Inc.(EXEL) | 1,525,730 | 1,525,730 | 0 | $50.81M | $56.33M | 11.75% | +$5.52M |
| Mineralys Therapeutics, Inc.(MLYS) | 1,011,155 | 2,149,667 | +1,138,512 | $12.45M | $34.14M | 7.12% | +$21.69M |
| Evolus, Inc.(EOLS) | 2,692,388 | 2,731,154 | +38,766 | $29.72M | $32.86M | 6.86% | +$3.13M |
| Sage Therapeutics Inc | 3,052,538 | 3,052,538 | 0 | $16.58M | $24.27M | 5.06% | +$7.69M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 2,995,932 | 3,107,669 | +111,737 | $22.53M | $23.31M | 4.86% | +$778.1K |
| Anika Therapeutics Inc | 1,435,130 | 1,435,130 | 0 | $23.62M | $21.57M | 4.50% | -$2.05M |
| Agios Pharmaceuticals, Inc.(AGIO) | 626,280 | 701,280 | +75,000 | $20.58M | $20.55M | 4.29% | -$32.1K |
| Revolution Medicines, Inc.(RVMD) | 0 | 465,000 | +465,000 | $0 | $16.44M | 3.43% | +$16.44M |
| Merus N V | 255,000 | 376,954 | +121,954 | $10.72M | $15.87M | 3.31% | +$5.14M |
| Y-Mabs Therapeutics Inc | 1,767,982 | 2,342,609 | +574,627 | $13.84M | $10.38M | 2.17% | -$3.47M |
| ABIVAX Société AnonymeADS(ABVX) | 752,167 | 1,269,119 | +516,952 | $5.51M | $7.93M | 1.66% | +$2.43M |
| Verrica Pharmaceuticals Inc.(VRCA) | 7,429,687 | 8,992,954 | +1,563,267 | $5.20M | $3.98M | 0.83% | -$1.22M |
| Rezolute, Inc.(RZLT) | 0 | 141,309 | +141,309 | $0 | $409.8K | 0.09% | +$409.8K |
| Tyra Biosciences, Inc.(TYRA) | 0 | 25,000 | +25,000 | $0 | $232.5K | 0.05% | +$232.5K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 184,826 | 0 | -184,826 | $1.06M | $0 | — | -$1.06M |